Endocrinology, Vol 137, 4061-4064, Copyright © 1996 by Endocrine Society

ARTICLES

Growth hormone (GH) therapy markedly increases the motility of spermatozoa and the concentration of insulin-like growth factor-I in seminal vesicle fluid in the male GH-deficient dwarf rat

BH Breier, MH Vickers, CG Gravance and PJ Casey
Research Centre for Developmental Medicine and Biology, School of Medicine, University of Auckland, New Zealand.

There is increasing evidence for an important role of the somatotropic axis in male reproductive function. We investigated the effect of recombinant bovine GH (rbGH) treatment for 21 days on semen characteristics in post-pubertal GH-deficient dwarf (dw/dw) rats. Male dw/dw rats at an age of 75-80 days were divided into two groups (n = 10 per group) and injected twice per day with either rbGH (2 micrograms/g/day) or saline. While the concentration (96.4 +/- 51.3 x 10(6) per ml) and morphology of spermatozoa (spermatozoa with normal morphology 73.5 +/- 6.3%) in the dw/dw rat were within the normal range, the motility of spermatozoa was very low (27.5 +/- 11.7%), establishing a state of sub-fertility. The rbGH treatment markedly increased (p < 0.01) motility of spermatozoa (44.5 +/- 10.7%) but did not change the concentration (144 +/- 80.3 x 10(6) per ml) and morphology (spermatozoa with normal morphology 79.5 +/- 6.0%). The rbGH treatment also significantly increased the concentration of insulin- like growth factor-I (IGF-I) in blood plasma (control 389.1 +/- 65 ng/ml, rbGH 813.9 ng/ml, p < 0.001) and in seminal vesicle fluid (control 11.3 +/- 3.0 ng/ml, rbGH 16.1 +/- 5.4 ng/ml, p < 0.05). We conclude that rbGH therapy markedly increases motility of spermatozoa in sub-fertile male GH-deficient dw/dw rats. Thus, GH therapy may offer considerable potential for the treatment of impaired male reproductive performance.

This article has been cited by other articles:

				A. Yilmaz, M. E. Davis, and R. C. M. Simmen Estimation of (co)variance components for reproductive traits in Angus beef cattle divergently selected for blood serum IGF-I concentration J Anim Sci, August 1, 2004; 82(8): 2285 - 2292. [Abstract] [Full Text] [PDF]

				M.L. Macpherson, R.C.M. Simmen, F.A. Simmen, J. Hernandez, B.R. Sheerin, D.D. Varner, P. Loomis, M.E. Cadario, C.D. Miller, S.P. Brinsko, et al. Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-2 and -5 in Equine Seminal Plasma: Association with Sperm Characteristics and Fertility Biol Reprod, August 1, 2002; 67(2): 648 - 654. [Abstract] [Full Text] [PDF]

				H. W. Davey, T. Xie, M. J. McLachlan, R. J. Wilkins, D. J. Waxman, and D. R. Grattan STAT5b Is Required for GH-Induced Liver Igf-I Gene Expression Endocrinology, September 1, 2001; 142(9): 3836 - 3841. [Abstract] [Full Text] [PDF]

				M. H. Vickers, B. A. Ikenasio, and B. H. Breier IGF-I Treatment Reduces Hyperphagia, Obesity, and Hypertension in Metabolic Disorders Induced by Fetal Programming Endocrinology, September 1, 2001; 142(9): 3964 - 3973. [Abstract] [Full Text] [PDF]

				M. H. Vickers, B. H. Breier, W. S. Cutfield, P. L. Hofman, and P. D. Gluckman Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E83 - E87. [Abstract] [Full Text] [PDF]

				V. Chandrashekar, A. Bartke, K. T. Coschigano, and J. J. Kopchick Pituitary and Testicular Function in Growth Hormone Receptor Gene Knockout Mice Endocrinology, March 1, 1999; 140(3): 1082 - 1088. [Abstract] [Full Text]